When it comes to treatment, AML patients and their care partners have much to consider. There are often many options available, each with advantages and disadvantages. Some people may seek clinical trials, others may have few feasible options. Understanding treatment options, goals, and what to expect are vital to achieving the best possible outcome for you.
We have resources to help you become actively engaged in determining the best, most-personalized treatment for your situation and how to plan for its effects.
Articles & Resources
Small Words, Big Differences: Best Practices in Supportive Care for Patients With AML
/in Acute Myeloid Leukemia, AML Newly Diagnosed, AML Programs, AML Resource ND, AML Resource WPS, AML Resources TC, AML Treatments and Clinical Trials, AML Whole Patient Support, Art Flatau /by Kara RayburnElevate | What You Should Know About Your Role in AML Treatment and Care Decisions Resource Guide
/in Acute Myeloid Leukemia, AML Elevate, AML Elevate Guides, AML Newly Diagnosed, AML Programs, AML Resource ND, AML Resources TC, AML Treatments and Clinical Trials /by Kara RayburnThriving With AML Resource Guide
/in Acute Myeloid Leukemia, AML Newly Diagnosed, AML Programs, AML Resource ND, AML Resource WPS, AML Resources T, AML Resources TC, AML Testing, AML Thrive, AML Thrive Guides, AML Treatments and Clinical Trials, AML Whole Patient Support /by Kara RayburnBlogs
FLT3 Inhibitors for AML Update
/in Acute Myeloid Leukemia, AML Blog ND, AML Blog TC, AML Newly Diagnosed, AML Treatments and Clinical Trials, Art Flatau, PEN Blog /by Art FlatauOlutasidenib for Relapsed or Refractory Acute Myeloid Leukemia with IDH1 Mutation
/in Acute Myeloid Leukemia, AML Blog ND, AML Blog TC, AML Newly Diagnosed, AML Treatments and Clinical Trials, PEN Blog /by Art FlatauAML Patient Profile: Jordan Supino
/in Acute Myeloid Leukemia, AML Blog ND, AML Blog TC, AML Blog WN, AML Blog WPS, AML Newly Diagnosed, AML Treatments and Clinical Trials, AML What's Next, AML Whole Patient Support, Patient Stories, PEN Blog /by GIna CraigPodcasts
![[ACT]IVATED Program Logo](https://powerfulpatients.org/wp-content/uploads/Program-page-image-option-1.png "[ACT]IVATED Program Logo")
What Are AML Inhibitor Therapies and How Do They Work?
/in Acute Myeloid Leukemia, AML Elevate, AML Elevate Treatment, AML Newly Diagnosed, AML Programs, AML Treatments and Clinical Trials, AML Video ND, AML Video TC /by Kara RayburnExpert Overview | AML Treatment Options and Phases of Therapy
/in Acute Myeloid Leukemia, AML Elevate, AML Elevate Treatment, AML Newly Diagnosed, AML Programs, AML Treatments and Clinical Trials, AML Video ND, AML Video TC /by Kara RayburnChoosing Therapy | How Are AML Treatment Goals Determined?
/in Acute Myeloid Leukemia, AML Elevate, AML Elevate Treatment, AML Newly Diagnosed, AML Programs, AML Treatments and Clinical Trials, AML Video ND, AML Video TC /by Kara Rayburn